Roche’s Virtual Neurology Investor Event
Roche has hosted a virtual event on Friday, 4 April 2025
| Agenda | |
|---|---|
| Introduction | Bruno Eschli, Head of Investor Relations |
| Neurology Update | Azad Bonni, SVP and Global Head of Neuroscience & Rare Diseases, Roche Pharma Research & Early Development |
| Prasinezumab in Parkinson’s disease: Ph IIb PADOVA data | Azad Bonni, SVP and Global Head of Neuroscience & Rare Diseases, Roche Pharma Research & Early Development |
| Trontinemab in Alzheimer’s disease: Ph Ib/II Brainshuttleᵀᴹ data | Luka Kulic, VP and Global Head of Early Development, Neuroscience & Rare Diseases, Roche Pharma Research & Early Development |
| Elevidys in Duchenne Muscular Dystrophy: Ph III EMBARK 2 yr data presented at MDA | Alex Murphy, Senior Clinical Director, Neuromuscular Disorders & Stroke, Roche |
| Q&A |